Title:
METHODS FOR TREATING CANCER USING VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR VEGI-192A
Document Type and Number:
WIPO Patent Application WO2005058243
Kind Code:
A3
Abstract:
The invention features methods and compositions for treating cancer by administering an effective amount of a VEGI-192A polypeptide. In some embodiments, the cancer is lung cancer or breast cancer.
Inventors:
LIN XINLI (US)
LI LUYUAN (US)
LI LUYUAN (US)
Application Number:
PCT/US2004/041729
Publication Date:
December 28, 2006
Filing Date:
December 13, 2004
Export Citation:
Assignee:
PROTEOMTECH INC (US)
UNIV PITTSBURGH (US)
LIN XINLI (US)
LI LUYUAN (US)
UNIV PITTSBURGH (US)
LIN XINLI (US)
LI LUYUAN (US)
International Classes:
A01N37/18; A61K38/16; A61K38/18; C07K1/00; A61K
Domestic Patent References:
| WO2003039491A2 | 2003-05-15 |
Foreign References:
| US20030170242A1 | 2003-09-11 |
Other References:
CHEW L.-J. ET AL., FASEB J., vol. 16, 2002, pages 742 - 744, XP002977765
Download PDF:
Previous Patent: CHEWABLE SOFT CAPSULES CONTAINING UNGELATINIZED STARCH
Next Patent: NOVEL ANTI-DC-SIGN ANTIBODIES
Next Patent: NOVEL ANTI-DC-SIGN ANTIBODIES